Cargando…
Brain metastasis in human epidermal growth factor receptor 2-positive breast cancer: from biology to treatment
Overexpression of human epidermal growth factor receptor 2 (HER2) is found in about 20% of breast cancer patients. With treatment using trastuzumab, an anti-HER2 monoclonal antibody, systemic control is improved. Nonetheless, the incidence of brain metastasis does not be improved, rather seems to be...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society for Radiation Oncology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831963/ https://www.ncbi.nlm.nih.gov/pubmed/27104161 http://dx.doi.org/10.3857/roj.2016.34.1.1 |